Colonoscopy Clinical Trial
Official title:
A Clinical Validation Study of Two Computerized Systems Called the 3D-Colonoscopy Progression Score and 3D-Colonoscopy Retraction Score
Colonoscopy is the considered gold standard for diagnosing diseases in the colon. A
colonoscopy is normally divided into the insertion from anus to cecum, the technical
difficult part, and a retraction or diagnostic part. No objective measure exists to evaluate
the performance of a colonoscopy. Based on a movement analysis of the colonoscope we wish to
seek evidence for an automated and objective system able to differentiate between
endoscopists with various experience in a clinical setting. The movement analysis is based on
information's from the colonoscope. Electromagnetic coils are built in along the length of
colonoscopes. They generate a pulsed magnetic field that is picked up a receiver coil. The
data-points for each coil are inserted into an algorithm for the movement analyzing. This
analysis is done as a change between the tip of the scope, and the next tracked magnetic
coil. The result is a relative movement of the colonoscope in relation to the previous
position.
The study is conducted a three different University Hospitals in Denmark. Twenty physicians
with experience in colonoscopy are voluntary included. Patients appointed to a screening
colonoscopy are included and a minimum of five consecutive colonoscopies are recorded for
each physician. We predict the system to be automated and objective tool correlated with the
physician's technical level of expertise in clinical colonoscopy.
Objectives:
1. Gather validity evidence for the 3D-Colonoscopy Progression score (3D-CoPS) and
3D-Colonoscopy Retraction Score (3D-CoRS) in a clinical setting.
2. Investigate the relationship between 3D-CoPS/3D-CoRS and a retrospective calculated
Adenoma Detection Rate (ADR) of endoscopists with various experience.
Background:
Colonoscopy is the gold standard for diagnosing adenomas and colorectal cancer. High Adenoma
Detection Rate (ADR) is essential to reduce the risk of subsequent colorectal cancer .To
maximize the detection of adenomas during a colonoscopy the endoscopist need to see as much
mucosa as possible. To increase the mucosa visualized quality indicators, such as bowel
preparatin, cecal intubation rate and an average time of at least 6 minutes spent during
withdrawal, should be used as supportive measures to minimize missed lesions and thereby
decreasing interval cancer. Bowel preparation, cecal intubation and time spent during
withdrawal are prerequisite measures for optimal visualization of the mucosa in the
colorectum, but are not a quality measure for actual detected pathology. Time as a quality
assurance for detection of adenomas means nothing if the physician isn't careful during
withdrawal and look behind folds and change position to get a clear view of the mucosa
surface. The ADR has been introduced as a surrogate measure of adequate visualization of the
mucosa, but a recommend and a minimum number of 500 colonoscopies are needed to calculate a
statistic reliable ADR. Although ADR is one of the most widely used and accepted quality
indicators great variance in number of performed procedures and ADR among physicians exits,
which makes ADR difficult to use in practice. Currently there is no quality parameter
evaluating the individual procedure and to our knowledge no objective tools exits to help
increase diagnostic accuracy during a colonoscopy. Objective, easy implementable and
automatic measures are needed to ensure a high detection of adenomas and subsequently prevent
missed lesions and interval cancers.
In collaboration with the Technical University of Denmark we have developed a score of
progression and retraction during a colonoscopy, called 3D-Colonoscopy Progression Score
(3D-CoPS) and 3D-Colonoscopy Retraction Score (3D-CoRS). We predict the systems to be
automated and objective tool correlated with the endoscopists technical level of expertise in
clinical colonoscopy.
Method and materials:
Retrospective study part:
The study is conducted at three different university hospitals. Twenty endoscopists with a
lifetime experience of no less than 50 screening colonoscopies are voluntarily enrolled. To
calculate the ADR for each endoscopist data of the last screenings colonoscopies is
retrospectively collected (minimum 50 colonoscopies per endoscopist).
The following will be noted for each endoscopist:
- Number of total colonoscopies
- Number of colonoscopies within the last year
- Number of other endoscopies
- Number of screenings colonoscopies
- Intern, junior resident, senior resident, consultant
- Surgical or medical gastrointestinal background
- Sex
- Age
- Time since graduation
Prospective part:
A minimum of five consecutive screenings colonoscopies for each endoscopist are included.
Patients appointed to a screening colonoscopy are chosen due to a higher ADR (approximately
50%) and a more homogeneous group. All procedures are performed with a standard Olympus
colonoscope model in combination with the Magnetic Endoscopy Imaging system (MEI). Data
collection starts at the intubation of the colonoscope in the anus and stops when the
procedure is finished. The data collection is fully automated without any interference from
the investigators during the normal clinical setup.
Approval is applied at the Danish Data Protection Agency, the Danish Patient Safety Authority
and the Regional Committee on Health Research Ethics.
General mathematical formulation for 3D-CoPS and 3D-CoRS:
Electromagnetic coils are built in along the length of the Olympus colonoscopes. They
generate a pulsed low-intensity magnetic field that is picked up a receiver coil. The
data-points for each coil are inserted into an algorithm for movement analyzing. The two main
measurements conducted in relation with the colonoscopy is the Colonoscopy Progression Score
(CoPS) and Colonoscopy Retraction Score (CoRS). Both of these have a joint basis for the
analysis, in the form of a movement analysis. This analysis is done as a vector product
between the tip of the scope, and the next tracked magnetic coil - where on the relative
magnitude of the change in position is multiplied on. This results in a relative movement
that is scaled with how much the scope moves in relation to the previous position, and how
much this movement is deflected according to the direction the tip points in. This movement
analysis is used for distinction between the progression- and retraction phase, which is
essential, such that the CoPS and CoRS measurements is performed at the right times.
3D-CoPS: To perform the CoPS measurement, the above definition helps by defining the
progression phase. The general belief is that if the scope progresses smoothly, the
colonoscopist is experienced, and vice versa. Therefor tracking how much time the tip of the
scope is "stagnant", is used to define the CoPS. Specifically, a two dimensional histogram is
used, spanned across the movement area of the colonoscopy. Filling the histogram is simply
performed by sampling the tip position at each time step, and putting it into the respective
bin. If the scope is then stagnant at many stages throughout the procedure, the bins values
will be locally very high. On the other hand, if a smooth progression is present, the bin
values will be smoothly distributed, across all the different bins. This is the basis for the
CoPS value. Finally followed with a normalizing, and scaling of the 2D histogram value, for
easing interpretation.
3D-CoRS: Analyzing the retraction phase, must be done differently, as the tip is supposed to
be stagnant, at different times, through this phase. Therefor the movement analysis, as
described above, is used to measure how the instrument moves. This movement is then
high-passed filtered, as experienced colonoscopist seems to have much more high frequency
movements, where-in the novices moves with much lower frequency (more hesitant). This overall
movement is evaluated as a difference between the different positions (by differentiation),
and a count of peaks and valleys is done with a fitting margin. This final count is then high
if an expert is performing the procedure, as more high frequency movements will take place,
and low if a novice is performing the procedure.
Patient related information:
- Number of polyps
- The polyp size
- Polyp type
- Polyp histology
- Polyp location
Validity:
Evidence of validity is based on Messicks five major sources (10).
Content:
1. 3D-CoPS and 3D-CoRS are being developed based on the evidence of an ongoing
simulation-based validation study " A Validation Study of a Computerized Movement Analysis of
the Colonoscope in Simulated Colonoscopy" and general good practice of how a colonoscope is
withdrawn from cecum to anus.
Response process:
The process is standardized using an Olympus colonoscope and MEI system. All participants
will be instructed informed of the systems and the data-collection. All data-collection
regarding are presented in a uniform file-format. The 3D-CoPS and 3D-CoRS are objective,
automated and unbiased tools.
Internal structure:
To ensure internal consistency of the 3D-CoPS and 3D-CoRS among the endoscopists a minimum of
5 consecutive colonoscopies are needed (based on an article not yet published). The score
system is automated and unbiased why the internal structure in this regard is consistent.
Relationship to other variables:
We assume the sample data reflects a population that follows a probability distribution based
on a fixed set of parameters. The correlation between experience (logarithmic) and scores
will be investigated using Pearson's r. Scores from 3D-CoPS and 3D-CoRS will be correlated
with patient and endoscopist variables. The endoscopist is not blinded during
data-collection, which might affect the performance. Even thou data collection is fully
automated, the technic during withdrawal of the colonoscope from caecum to anus could change
and increase mucosa visualized and therefore polyp detection (increased awareness of the
endoscopist).
Consequences:
Contrasting groups' method will be used to set a pass/fail standard based on the scores
imitating aminimum performance during intubation, a minimum ADR and false positive and false
negative will be investigated.
Ethics:
The study contains no biomedical involvement. Participants and patients will not suffer from
any physical or psychological discomfort. All endoscopists will be provided with oral and
written information and sign a letter of informed consent before entering the study. The
collected data are anonymized.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04101097 -
Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
|
||
Completed |
NCT03247595 -
Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy
|
N/A | |
Completed |
NCT04214301 -
An Open-Label Preference Evaluation of BLI800
|
Phase 4 | |
Withdrawn |
NCT05754255 -
Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center
|
N/A | |
Recruiting |
NCT02484105 -
Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction
|
Phase 4 | |
Active, not recruiting |
NCT02264249 -
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
|
N/A | |
Completed |
NCT01964417 -
The Comparative Study Between Bowel Preparation Method
|
Phase 3 | |
Terminated |
NCT01978509 -
The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies
|
N/A | |
Recruiting |
NCT01685970 -
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
|
Phase 3 | |
Completed |
NCT01518790 -
Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children
|
N/A | |
Recruiting |
NCT00748293 -
Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet
|
N/A | |
Completed |
NCT00779649 -
MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial
|
Phase 4 | |
Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
Completed |
NCT00380497 -
Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children
|
Phase 4 | |
Recruiting |
NCT00160823 -
Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
|
Phase 3 | |
Completed |
NCT00390598 -
PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
|
Phase 2/Phase 3 | |
Completed |
NCT00314418 -
Patient Position and Impact on Colonoscopy Time
|
N/A | |
Completed |
NCT00209573 -
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
|
Phase 3 | |
Completed |
NCT00427089 -
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
|
Phase 3 | |
Completed |
NCT05823350 -
The Effect of Abdominal Massage on Pain and Distention After Colonoscopy
|
N/A |